Human PADI4 / PAD4 Baculovirus-Insect Overexpression Lysate: Product Information
This Human PADI4 / PAD4 overexpression lysate was created in Baculovirus-Insect Cells and intented for use as a Western blot (WB) positive control. Purification of PADI4 / PAD4 protein (Cat: 11072-H07B) from the overexpression lysate was verified.
A DNA sequence encoding the human PADI4 (Met1-Pro663) was expressed with a polyhistidine tag at the N-terminus.
The recombinant human PADI4 consists 663 amino acids and predicts a molecular mass of 74 kDa.
Human PADI4 / PAD4 Baculovirus-Insect Overexpression Lysate: Usage Guide
Cell lysate was prepared by homogenization of the over-expressed cells in ice-cold modified RIPA Lysis Buffer with cocktail of protease inhibitors (Sigma). Cell debris was removed by centrifugation. Protein concentration was determined by Bradford assay (Bio-Rad protein assay, Microplate Standard assay). The cell lysate was boiled for 5 min in 1 x SDS loading buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% b-mercaptoethanol, and lyophilized.
1. Centrifuge the tube for a few seconds and ensure the pellet at the bottom of the tube.
2. Re-dissolve the pellet using 200μL pure water and boil for 2-5 min.
1 X Sample Buffer (1 X modified RIPA buffer+1 X SDS loading buffer).
Stability & Storage
Store at 4℃ for up to twelve months from date of receipt. After re-dissolution, aliquot and store at -80℃ for up to twelve months. Avoid repeated freeze-thaw cycles.
Western Blot (WB) Optimal dilutions/concentrations should be determined by the end user.
Human PADI4 / PAD4 Baculovirus-Insect Overexpression Lysate: Alternative Names
Human PAD Overexpression Lysate; Human PAD4 Overexpression Lysate; Human PADI5 Overexpression Lysate; Human PDI4 Overexpression Lysate; Human PDI5 Overexpression Lysate
PADI4 / PAD4 Background Information
Protein-arginine deiminase type-4, also known as HL-6 PAD, Peptidylarginine deiminase IV, Protein-arginine deiminase type IV and PADI4, is a cytoplasm and nucleus protein which belongs to theprotein arginine deiminase family. PADI4 is expressed in CD34+ stem cells in normal tissues, and many more CD34+ cells expressing PADI4 are present in tumour tissues. PADI4 post-translationally converts peptidylarginine to citrulline, a process called citrullination. Studies have demonstrated the high expression of PADI4 in various malignant tumour tissues. PADI4 is also expressed at high levels in the blood of patients with some malignant tumours. Citrullination of histone, cytokeratin, antithrombin and fibronectin have been confirmed to be involved in abnormal apoptosis, high coagulation, and disordered cell proliferation and differentiation, all of which are main features of malignant tumours. PADI4 may play an important role in tumourigenesis. Genetic variations in PADI4 are a cause of susceptibility to rheumatoid arthritis (RA). It is a systemic inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures.
peptidyl arginine deiminase, type IV
Nakashima K. et al.,1999, J. Biol. Chem. 274: 27786-92.
Suzuki A. et al., 2003, Nat. Genet. 34:395-402.
Nakayama-Hamada M. et al., 2005, Biochem. Biophys. Res. Commun. 327:192-200.
Successfully added to cart Please enter catalog numberSubmitted successfullyNetwork ErrorPlease enter your company namePlease enter your namePlease enter your emailPlease enter a valid email addressPlease enter some messageNot found.